Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients

Journal of International Medical Research

Volumn 31, Issue 5, 2003, Pages 362-369

  Watanabe, H ^a   Yamaguchi, N ^a   Kuwayama, H ^b   Sekine, C ^c   Uemura, N ^d   Kaise, M ^e   Nakamura, T ^f   Kubo, M ^g   Yoshida, S ^h   Haruma, K ⁱ   Inoue, M ^j   Shimatani, T ^j   Sanuki, E ^k   Mieno, H ^l   Kawanishi, M ^m   Nakazawa, S ⁿ   Tanaka, T ^o  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Saiseikai Kawaguchi General Hospital   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Kitano Hospital   (Japan)

^g OSAKA POLICE HOSPITAL   (Japan)

^h Akashi City Hospital   (Japan)

ⁱ KAWASAKI MEDICAL SCHOOL   (Japan)

^j HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^k Saiseikai Hiroshima Hospital   (Japan)

^l HIROSHIMA GENERAL HOSPITAL   (Japan)

^m Hiroshima Mitsubishi Hospital   (Japan)

ⁿ Yamashita Hospital   (Japan)

^o ASTRAZENECA   (United Kingdom)

more..

Author keywords

Amoxicillin; Clarithromycin; Gastric mucosal histology; Helicobacter pylori; Omeprazole

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; ARTICLE; ATROPHY; CELL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; ERADICATION THERAPY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; JAPAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NEUTROPHIL; PEPTIC ULCER; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH MUCOSA; TREATMENT FAILURE;

EID: 10744227674     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000303100502     Document Type: Article

References (17)

1. Warren JR: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273.
2. Labenz J, Gyenes E, Rühl GH, Börsch G: Helicobacter pylori re-infection and clinical course of peptic ulcer disease in the first year post-amoxicillin/omeprazole treatment. Eur J Gastroenterol Hepatol 1992; 4: 893-896.
3. Bayerdörffer E, Mannes GA, Sommer A, Höchter W, Weingart J, Hatz R, et al. Long-term follow up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin. Scand J Gastroenterol 1993; 28 (Suppl 196): 19-25.
4. Soll AH: Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 1996; 275: 622-629.
5. NIH Consensus Conference: Helicobacter pylori in Peptic Ulcer Disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994; 272: 65-69.
6. Logan RPH, Gummett PA, Schaufelberger HD, Greaves RR, Mendelson GM, Walker MM, et al: Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35: 323-326.
7. Labenz J, Stolte M, Domian C, Bertrams J, Börsch G: High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease. Digestion 1995; 56: 14-20.
8. Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdörffer E, O'Morain C, et al: Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter 1996; 1: 138-144.
9. Lind T, Mégraud F, Unge P, Bayerdörffer E, O'Morain C, Spiller R, et al: The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999; 116: 248-253.
10. Asaka M, Sugiyama T, Kato M, Satoh K, Kuwayama H, Fukuda Y, et al. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter 2001; 6: 254-261.
11. Haruma K, Mihara M, Okamoto E, Kusunoki H, Hananoki M, Tanaka S, et al: Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus - evaluation of 24-h pH monitoring. Aliment Pharmacol Ther 1999; 13: 155-162.
12. Tucci A, Poli L, Tosetti C, Biasco G, Grigioni W, Varoli O, et al: Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 1998; 93: 1425-1431.
13. Ciok J, Dzieniszewski J, Lucer C: Helicobacter pylori eradication and antral intestinal metaplasia - two years' follow-up study. J Physiol Pharmacol 1997; 48 (Suppl 4): 115-122.
14. Ohkusa T, Fujiki K, Takashimizu I, Kumagai J, Tanizawa T, Eishi Y, et al: Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134: 380-386.
15. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston, 1994. Am J Surg Pathol 1996; 20: 1161-1181.
16. Farinati F, Foschia F, Di Mario F, Cassaro M, Rugge M: H. pylori eradication and gastric precancerous lesions. Gastroenterology 1998; 115: 512-514.
17. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.